ATYR aTyr Pharma, Inc

$ATYR Getting a little ridiculous at $24 million market cap. Second Quarter 2026 Financial Highlights and Cash Position Cash & Investment Position: Cash, cash equivalents, restricted cash and available-for-sale investments as of June 30, 2026, were $58.9 million. Based on its current cash and new operating expense forecast and plans, the Company anticipates that this cash position will be sufficient to fund the Company’s current operations into late 2028. Future development of efzofitimod in the planned Phase 3 study in pulmonary sarcoidosis will require the Company to obtain additional capital through equity or debt offerings, grant funding, collaborations, strategic partnerships and/or licensing arrangements.

$ATYR with their +50mln on the bank, they should allocate around 10mln to buy back shares and squeeze these shorts... and then raise the funds needed for the P3 at a much higher price.

Latest company news, October 19, 2026: aTyr announced a research collaboration with Albert Einstein College of Medicine on ATYR2810, its NRP2-targeting antibody. Financial terms not disclosed. ATyr ($ATYR): New Lung Study, Cash And Funding Deeper dive in our hub. Not investment advice.

$ATYR partnered with Montefiore Einstein on a research collaboration to develop its NRP2-targeting antibody ATYR2810.

$ATYR short sellers are more scared than long investors because they can lose indefinitely as soon as this will move just a little bit you will see it move very fast remember what I'm saying

$ATYR FDA News 🗞️Adding✅ aTyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis 💹

$ATYR +5.28% on a risk-off day when the Nasdaq ends down 1.13%, Brent futures up to $103, and the 10 yr at 5.1%. Seems like the street heard a whisper.

$ATYR The tide is turning, RS is priced in.. what is not priced in are the good results on the way.. expect the price to rise up from here on now..

$ATYR Nothing that is happening is a surprise. The market is waiting for/expecting a reverse split and dilution and is repricing accordingly.

$ATYR Man with that kind of VOLUME and still held DOWN?? Baby wants to FLY….. Release meeee

$ATYR reached alignment with the FDA on its Phase 3 protocol for efzofitimod in pulmonary sarcoidosis.

$ATYR I'm not letting them get all the shares on the cheap I'm slapping the ask again today .If they want them and cheap then so do I...Hold for Gold

$ATYR People keep saying the news today was good. It wasn’t bad, but not the same as FDA approval.

$ATYR The people on here whining about such trivial things like a reverse split or the need for financing are blind to the bigger picture. The Connect Phase 2, top-line data drops in Q1. If they knock this for six, it will validate the newly designed Efzo-Fit trial and the same people whining now will be either adding or re-entering alongside major healthcare funds.

$ATYR this Is Crazy.. I understood the rule "sell the news", but normally that rule After the other One "buy the rumors" , but this ticker plunge from .5 tò.37 in the post two weeks....

$ATYR $90M cash and cash equivalents and only a $37M MC. This is going to be very interesting to say the least! This is one for the long bucket!

$ATYR The R/S ensures Nasdaq compliance and financing funds the trial. Neither changes the underlying value of the asset. They’re hurdles to navigate, not value-creation events. That will only come from Connect and the newly designed Phase 3.

$ATYR Bullish? You can only laugh at this sentiment; it's utter rubbish. This will probably be my second dead weight in my portfolio after Nucana, following the RS.

$ATYR hoping tò return highly green because today we are supported by very huge volume more than 100 m stocks alREady exchanged, and the MOST of them at higher price compaRed tò the current level

$ATYR This is pulling back on fears of a rate hike… They won’t need an offering until around this time next year. How dumb can the market be? The catalyst is that the clinical program has moved forward to the next stage…